DexCom, Inc. (DXCM) CEO Terrance Gregg says the company recently penetrated the pediatric market. He says DexCom received a pediatric label expansion, allowing the company to promote its glucose monitors for pediatric patients as young as two.
“And we’ve never before actually called on that pediatric prescribing base, so that allowed our field sales force now to open up a new market,” Gregg says. “Going into 2014, our installed base of less than 18 years of age was about 8% to 10%, but of course that was off-label use by the prescribing population.”
FOR MORE INFORMATION ON THIS INTERVIEW CLICK HERE.
Gregg says DexCom can now use on-label promotion within the pediatric community, and has already seen an uptick in use of its products by pediatric patients.
“And in fact, today, about 20% to 21% of our shipments are going to that pediatric community, which is a particularly strong community in adoption of this type of technology,” Gregg says.
Ryan Zimmerman Wants You to Invest in this Pediatric Surgical Equipment Company
July 22, 2019
Community Banks are Toast States Richard Bove, the CEO of Dime Community Bank (NASDAQ:DCOM) Disagrees
July 28, 2021
Greek Shipping Company Navios Maritime (NM) Provides Rescue for German HSH NordBank Loans Close to Default
April 23, 2013
Dry Bulk Shipping Investment Vehicle is a First for Market
November 23, 2020
Maritime Decarbonization Technology Index: Cleaner Shipping for a Cleaner World
January 24, 2022
